Amyloid-β clearance: an astrocytic perspective

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Cell Biology

Background:

• Alzheimer's disease (AD) is a leading cause of mortality and socioeconomic burden.
• Pathological hallmark of AD is amyloid-beta (Aβ) imbalance, leading to aggregation and neurodegeneration years before symptoms.
• Current therapies targeting Aβ production show limited success; early Aβ clearance interventions are gaining traction.

Purpose of the Study:

• To review astrocyte-mediated Aβ clearance mechanisms.
• To explore astrocyte roles in blood-brain barrier maintenance and glymphatic drainage.
• To identify astrocyte phenotypic changes and functional decline in AD pathology.

Main Methods:

• Literature review synthesizing recent findings on astrocyte-AD pathology.
• Focus on molecular mechanisms of astrocyte Aβ uptake and degradation.
• Analysis of astrocyte roles in blood-brain barrier integrity and glymphatic transport.

Main Results:

• Astrocytes clear Aβ via endocytosis and intracellular degradation.
• Astrocyte function in blood-brain barrier maintenance and aquaporin-4 (AQP4)-dependent glymphatic drainage is crucial for Aβ clearance.
• Astrocyte phenotypic plasticity and pathological decline dynamically modulate Aβ clearance capacity.

Conclusions:

• Astrocytes play a significant, underexplored role in Aβ clearance.
• Understanding astrocyte mechanisms provides a basis for astrocyte-targeted early AD interventions.
• Targeting astrocyte functions offers a promising translational approach for AD therapy.